The Cannabis Industry’s 20 Hottest Pot Stocks of 2019

With mergers and acquisitions moving at a fast pace, it’s hard to know which cannabis companies are the best values. Last year, we provided a list of the Top 12 Canadian Pot Stocks. Here’s an expanded 2019 list that includes U.S. companies investors are high on.

Acreage Holdings

OTC: ACRGF

Based: New York, NY

Cap: $1.65 billion

Stock price: $19.10

About: Holds dispensary and cultivation licenses in 10 states; former Speaker of the House John Boehner And Canadian Prime Minister Brian Mulroney are on their board.

Related Article: They Say It’s an Evolution: On John Boehner’s Cannabis Switcheroo

Aphria Inc.

NYSE: APHA

Based: Leamington, ON

Cap: $2.55 billion

Stock price: $10.31

About: The Canadian licensed producer faced a short seller in 2018. Note: Licensed producers are legally allowed to cultivate in Canada.

Related Article: Quintessential Capital Challenges Aphria

Aurora Cannabis Inc.

NYSE: ACB

Based: Cremona, AB

Cap: $7.33 billion

Stock Price: $7.30

About: The Canadian licensed producer met with Coca-Cola in 2018

Canopy Growth Corp.

NYSE: CGC

Based: Smiths Falls, ON

Cap: $16.10 billion

Stock price: $47.10

About: The Canadian licensed producer sold 38% of the company to alcohol maker Constellation Brands in 2018

Charlotte’s Web Holdings Inc.

OTC: CWBHF

Based: Boulder, CO

Cap: $259.43 million

Stock price: $14.16

About: Produces hemp and CBD products under the CW Hemp brand

Cronos Group Inc.

NASDAQ: CRON

Based: Toronto, ON

Cap: $3.91 billion

Stock Price: $21.75

About: The Canadian licensed producer sold 45% of company to tobacco giant Altria Group in 2018

Related Article: Big Tobacco Makes Major Move into Canadian Cannabis Market

Curaleaf Holdings Inc.

OTC: CURLF

Based: Wakefield, MA

Cap: $3.48 billion

Stock Price: $7.60

About: Holds dispensary and cultivation licenses in 10 states

Freedom Leaf Health

OTC: FRLF

Based: Las Vegas, NV

Cap: $49.70 million

Stock Price: $0.22

About: Publishes Freedom Leaf magazine and manufactures hemp-CBD products

Related Article: Freedom Dives into the Hemp/CBD Market

Green Organic Dutchman Holdings Ltd.

OTC: TGODF

Based: Mississauga, ON

Cap: $893.06 million

Stock Price: $3.29

About: Canadian licensed producer

GW Pharmaceuticals

NASDAQ: GWPH

Based: Cambridge, UK

Cap: $5.4 billion

Stock Price: $177.49

About: Maker of Sativex and Epidiolex, both approved by the FDA

Related Article: The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approvals?

Hexo Corp.

OTC: HEXO

Based: Gatineau, QB

Cap: $1.17 billion

Stock Price: $5.67

About: The Canadian licensed producer partnered with Molson Coors Canada in 2018

iAnthus Capital Holdings Inc.

OTC: ITHUF

Based: New York, NY

Cap: $407.62 million

Stock Price: $5.47

About: Holds dispensary and cultivation licenses in seven states

KushCo Holdings Inc.

OTC: KSHB

Based: Garden Grove, CA

Cap: $521.81 million

Stock Price: $5.94

About: Manufactures packaging products for the cannabis industry

Liberty Health Sciences

OTC: LHSIF

Based: Toronto, ON

Cap: $233.81 million

Stock Price: $0.82

About: Holds dispensary and cultivation licenses in Florida

MedMen Enterprises

OTC: MMNFF

Based: Culver City, CA

Cap: $351.07 million

Stock Price: $2.96

About: Holds dispensary and cultivation licenses in five states

Related Article: MedMen Defend Itself Over Parker Suit

MPX Bioceutical Corp.

Other OTC: MPXEF

Based: Toronto, ON

Cap: $3.4 million

Stock Price: $0.92

About: Holds dispensary and cultivation licenses in three states and owns Melting Point Extracts

Scotts Miracle-Gro Company

NYSE: SMG

Based: Dayton, OH

Cap: $4.53 billion

Stock Price: $81.80

About: Manufactures soil, fertilizer and hydroponic gardening equipment

Terra Tech Corp.

OTC: TRTC

Based: Irvine, CA

Cap: $69.69 million

Stock Price: $0.88

About: Holds dispensary and cultivation licenses in two states

Therapix Biosciences Ltd.

NASDAQ: TRPX

Based: Givatayim, Israel

Cap: $12.71 million

Stock Price: $4.61

About: Pharma company moving into cannabis formulations for specific conditions

Tilray Inc.

NASDAQ: TLRY

Based: Nanaimo, BC

Cap: $7.41 billion

Stock Price: $79.50

About: The Canadian licensed producer partnered with pharma and alcohol companies in 2018

Related Article: Tilray Makes Deals with Novartis and Anheiser-Busch